Modulation of gastric emptying and gastrointestinal transit in rats through intestinal cannabinoid CB1 receptors

European Journal of Pharmacology

Volumn 450, Issue 1, 2002, Pages 77-83

  Landi, Marco ^a   Croci, Tiziano ^a   Rinaldi Carmona, Murielle ^b   Maffrand, Jean Pierre ^b   Le Fur, Gérard ^b   Manara, Luciano ^a  

^a Sanofi Midy Research Center   (Italy)

^b SANOFI   (France)

Author keywords

Cannabinoid CB1 receptor; Gastric emptying; Gastrointestinal transit; Pertussis toxin

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; CANNABINOID 1 RECEPTOR; CANNABINOID RECEPTOR AGONIST; CANNABINOID RECEPTOR ANTAGONIST; PERTUSSIS TOXIN; RIMONABANT; CANNABINOID; CANNABINOID RECEPTOR; CYCLOHEXANOL DERIVATIVE; DRUG RECEPTOR; MORPHOLINE DERIVATIVE; NAPHTHALENE DERIVATIVE; PIPERIDINE DERIVATIVE; PYRAZOLE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENCY; GASTROINTESTINAL TRANSIT; INTESTINE TRANSIT TIME; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STOMACH EMPTYING; ANALYSIS OF VARIANCE; ANIMAL; COMPARATIVE STUDY; DOSE RESPONSE; DRUG ANTAGONISM; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; METABOLISM; ORAL DRUG ADMINISTRATION; PHYSIOLOGY;

ADMINISTRATION, ORAL; ANALYSIS OF VARIANCE; ANIMAL; CANNABINOIDS; COMPARATIVE STUDY; CYCLOHEXANOLS; DOSE-RESPONSE RELATIONSHIP, DRUG; GASTRIC EMPTYING; GASTROINTESTINAL TRANSIT; INJECTIONS, INTRAVENTRICULAR; MALE; MORPHOLINES; NAPHTHALENES; PIPERIDINES; PYRAZOLES; RATS; RECEPTORS, DRUG; ANIMALS; RECEPTORS, CANNABINOID;

EID: 0037118910     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(02)02053-8     Document Type: Article

References (42)

1. Pertussis toxin blocks the outer current evoked by opiate and alpha-2 agonists in locus coeruleus neurons
2. A simple and inexpensive cannula technique for chemical stimulation of the brain
3. Cannabinoid-receptor expression in human leukocytes
4. A selective inverse agonist from central cannabinoid receptor inhibits mitogen-activated protein kinase activation stimulated by insulin-like growth factor 1. Evidence for a new model of receptor/ligand interactions
5. Inhibition of intestinal motility by anandamide, an endogenous cannabinoid
6. The effect of cannabinoids on intestinal motility and their antinociceptive effect in mice
7. Cannabinoid modulation of intestinal propulsion in mice
8. Inhibition by cannabinoid receptor agonists of acetylcholine release from the guinea-pig myenteric plexus
9. Anandamide, an endogenous ligand of the cannabinoid receptor, induces hypomotility and hypothermia in vivo in rodents
10. Promotion by SR48692 of gastric emptying and defecation in rats suggesting a role of endogenous neurotensin
11. In vitro functional evidence of neuronal cannabinoid CB1 receptors in human ileum
12. Determination and characterization of a cannabinoid receptor in rat brain
13. Cannabinoid receptors and their endogenous agonists
14. Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations
15. Localization of cannabinoid receptors in brain and periphery
16. Pharmacology of cannabinoid receptors
17. Excitatory transmission to the circular muscle of the guinea-pig ileum: Evidence for the involvement of cannabinoid CB1 receptors
18. Defaecation, intestinal fluid accumulation and motility in rodents: Implications of cannabinoid CB1 receptors
19. Central and peripheral cannabinoid modulation of gastrointestinal transit in physiological states or during the diarrhoea induced by croton oil
20. 1 receptors
21. 1-cannabinoid receptor immunoreactivity in the porcine enteric nervous system
22. The central and peripheral influences of opioids on gastrointestinal propulsion
23. 1 receptors
24. Functional assessment of neuronal cannabinoid receptors in the muscular layers of human ileum and colon
25. Antinociceptive actions of cannabinoids following intraventricular administration in rats
26. Structure of a cannabinoid receptor and functional expression of the cloned cDNA
27. Pertussis toxin modifies the effect of central morphine on rat intestinal motility
28. Central and peripheral inhibition of gastrointestinal transit in rats: Narcotics differ substantially by acting at either or both levels
29. 2 receptors
30. Cannabinoids and the gastrointestinal tract
31. Inhibitory effects of certain enantiomeric cannabinoids in the mouse vas deferens and the myenteric plexus preparation of guinea-pig small intestine
32. 1 receptors in guinea-pig small intestine
33. Cannabinoid penetration into mouse brain as determined by ex vivo binding
34. Choosing near-linear parameters in the four-parameter logistic model for radioligand and related assays
35. SR141716A, a potent and selective antagonist of the brain cannabinoid receptor
36. 2 cannabinoid receptor
37. Comparison of cannabinoid binding sites in guinea-pig forebrain and small intestine
38. 1 cannibinoid receptor antagonist SR 141716 in rats as assessed by electroencephalografic spectral and sleep-waking cycle analysis
39. Psychoactive cannabinoids reduce gastrointestinal propulsion and motility in rodents
40. The central and peripheral effects of Delta-9-tetrahydrocannabinol on gastrointestinal transit in mice
41. Effect of tetrahydrocannabinol on gastric emptying of solids in humans